On Monday, Arrowhead Pharmaceuticals ... receives a $500 million upfront payment and $325 million through Sarepta stock. Price Action: ARWR stock is down 8.72% at $15.49 at the last check Monday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback